Sanofi India announced that it has received marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for Beyfortus. Beyfortus is intended to prevent Respiratory...
Lupin, the drug firm has received the approval from India’s Central Drugs Standard Control Organisation (CDSCO) for Bepotastine tablets that are used in treating patients...